Investing in Health for All

Investing-In-Health-For-All_Thumbnail_FinalPlay

Between acute crises like the COVID-19 pandemic and longer-running problems like the failure to manage preventable infectious and chronic diseases, global public health has suffered from shortcomings in both the public and private sectors, and in governance at all levels. While there are no one-size-fits-all solutions, investment and policy leadership are key to setting the right priorities and then delivering on them. What will it take to build more resilient health systems, drive financing and access to new drugs, and foster cross-border and -sectoral collaboration toward shared health goals?

 

Organized by:

Speakers

Agenda

Moderator: Rosanna Lockwood
1:30PMKeynote Address and Fireside Chat
  1. Werner Hoyer, President of the European Investment Bank
  2. Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization
1:55PMQ&A with International Media
  1. Werner Hoyer, President of the European Investment Bank
  2. Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization
2:05PMRemarks
  1. Stella Kyriakides, Commissioner of Health and Food Safety at the European Commission
2:10PMBreak
Session One – The Anatomy of Resilience
Despite earlier warnings that the world was vulnerable to pandemics, the COVID-19 crisis came as an unprecedented shock to our current health systems and showed many countries to be utterly unprepared for such an event. What will it take to build more resilient health systems that are capable and ready to prevent future disease outbreaks and health emergencies?
2:25PMOpening Remarks
  1. Thomas Östros, Vice President of the European Investment Bank
2:30PMPanel Discussion
  1. Marie-Ange Saraka-Yao, Managing Director for Resource Mobilization, Private-Sector Partnerships, and Innovative Finance at Gavi, the Vaccine Alliance
  2. John F. Ryan, Acting Deputy Director-General of the Directorate-General for Health and Food Safety at the European Commission
  3. Samira Asma, Assistant Director-General for the Data, Analytics, and Delivery for Impact Division at the World Health Organization
  4. Felicitas Riedl, Director of Innovation and Competitiveness at the European Investment Bank

  5. Featuring: Fernando Prados Roa, Director-General of Integrated Health Process for Consejería de Sanidad de la Comunidad de Madrid
3:00PMClosing Remarks
  1. Sandra Gallina, Director-General of Health and Food Safety at the European Commission
3:05PMBreak
Session Two – The Race Against Disease
Over the past century, humanity has made enormous progress in fighting infectious diseases through improved hygiene and sanitation and the development and deployment of vaccines and therapeutics. But persistent disparities in access underscore the need for new approaches to financing research and innovation into infectious diseases, novel treatments, models of care, and detection and surveillance.
3:20PMOpening Remarks
  1. Signe Ratso, Acting Director-General of Research and Innovation at the European Commission
3:25PMPanel Discussion
  1. Jeremy Farrar, Director of the Wellcome Trust
  2. Barbara Kerstiens, Head of the Combatting Diseases unit in the Directorate-General for Research and Innovation at the European Commission
  3. Wolfgang Philipp, Acting Director of the Directorate-General for Health Emergency Preparedness and Response Authority at the European Commission
  4. John Reeder, Director of the Special Program for Research and Training in Tropical Diseases at the World Health Organization

  5. Featuring: Mary Lou Valdez, Deputy Director of the Pan American Health Organization
3:55PMClosing Remarks
  1. Laura Piovesan, Deputy Director-General of the Projects Directorate at the European Investment Bank
4:00PMBreak
Session Three – Health Without Borders
Achieving “good health and well-being for all” requires common purpose and broad collaborative efforts by people and organizations across countries and sectors – both public and private. Though geopolitical tensions are higher than they have been in decades, so too is the need for greater public-health coordination among governments, international institutions, multinationals, and global networks.
4:15PMOpening Remarks
  1. Martin Seychell, Deputy Director-General of the Directorate-General for International Partnerships at the European Commission
4:20PMPanel Discussion
  1. Özlem Türeci, Co-Founder and Chief Medical Officer of BioNTech
  2. Peter Piot, Special Adviser on COVID-19 to the President of the European Commission
  3. Gaudenz Silberschmidt, Director of Health and Multilateral Partnerships at the World Health Organization
  4. Vidya Vasu-Devan, Director of the Strategic Investment Fund at the Bill & Melinda Gates Foundation
4:50PMClosing Remarks
  1. Christoph Kuhn, Director of the Mandate Management Department at the European Investment Bank
4:55PMClosing Keynote
  1. Helen Clark, Former Prime Minister of New Zealand

Our Partners

What they are saying

  1. Many people here at the bank agree that this was the most professional looking, well moderated, and entertaining event we have supported or participated in... The speakers were top-level and highly knowledgable throughout, and the whole design was very slick.

    Dirk Heilmann
    Photo of Dirk Heilmann

Featured Events

  1. The Energy Revolution
    Photo of The Energy Revolution

    The Energy Revolution

    To ensure that the green transition serves everyone, how should stakeholders come together to leverage innovations in not just technology but also policy and finance? Join us LIVE from COP27 in Sharm El-Sheikh, Egypt.